Balchem Corporation
BCPC
$169.03
-$1.34-0.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 263.62M | 267.56M | 255.47M | 250.52M | 240.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 263.62M | 267.56M | 255.47M | 250.52M | 240.00M |
| Cost of Revenue | 169.72M | 172.11M | 162.35M | 162.35M | 153.67M |
| Gross Profit | 93.90M | 95.45M | 93.11M | 88.17M | 86.34M |
| SG&A Expenses | 36.56M | 36.38M | 37.37M | 32.00M | 34.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 211.33M | 212.98M | 204.03M | 199.02M | 192.56M |
| Operating Income | 52.29M | 54.58M | 51.44M | 51.50M | 47.44M |
| Income Before Tax | 50.04M | 52.04M | 49.01M | 47.94M | 44.48M |
| Income Tax Expenses | 10.81M | 11.76M | 10.73M | 10.89M | 10.90M |
| Earnings from Continuing Operations | 39.23M | 40.29M | 38.28M | 37.05M | 33.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.23M | 40.29M | 38.28M | 37.05M | 33.58M |
| EBIT | 52.29M | 54.58M | 51.44M | 51.50M | 47.44M |
| EBITDA | 63.72M | 66.20M | 62.84M | 62.45M | 58.05M |
| EPS Basic | 1.23 | 1.25 | 1.18 | 1.14 | 1.03 |
| Normalized Basic EPS | 0.98 | 1.01 | 0.95 | 0.93 | 0.85 |
| EPS Diluted | 1.21 | 1.24 | 1.17 | 1.13 | 1.03 |
| Normalized Diluted EPS | 0.97 | 1.00 | 0.94 | 0.92 | 0.85 |
| Average Basic Shares Outstanding | -- | 32.27M | 32.35M | 32.44M | 32.55M |
| Average Diluted Shares Outstanding | 32.60M | 32.60M | 32.68M | 32.81M | 32.55M |
| Dividend Per Share | 0.96 | -- | -- | -- | 0.87 |
| Payout Ratio | 0.03% | 0.03% | 0.01% | 76.28% | 0.01% |